JPWO2023106256A5 - - Google Patents

Info

Publication number
JPWO2023106256A5
JPWO2023106256A5 JP2023566307A JP2023566307A JPWO2023106256A5 JP WO2023106256 A5 JPWO2023106256 A5 JP WO2023106256A5 JP 2023566307 A JP2023566307 A JP 2023566307A JP 2023566307 A JP2023566307 A JP 2023566307A JP WO2023106256 A5 JPWO2023106256 A5 JP WO2023106256A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
associated virus
virus vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023566307A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023106256A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/044701 external-priority patent/WO2023106256A1/ja
Publication of JPWO2023106256A1 publication Critical patent/JPWO2023106256A1/ja
Publication of JPWO2023106256A5 publication Critical patent/JPWO2023106256A5/ja
Pending legal-status Critical Current

Links

JP2023566307A 2021-12-06 2022-12-05 Pending JPWO2023106256A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021198101 2021-12-06
PCT/JP2022/044701 WO2023106256A1 (ja) 2021-12-06 2022-12-05 改変型アデノ随伴ウイルスベクター

Publications (2)

Publication Number Publication Date
JPWO2023106256A1 JPWO2023106256A1 (cg-RX-API-DMAC7.html) 2023-06-15
JPWO2023106256A5 true JPWO2023106256A5 (cg-RX-API-DMAC7.html) 2025-12-04

Family

ID=86730352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023566307A Pending JPWO2023106256A1 (cg-RX-API-DMAC7.html) 2021-12-06 2022-12-05

Country Status (5)

Country Link
US (1) US20250099619A1 (cg-RX-API-DMAC7.html)
EP (1) EP4446418A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023106256A1 (cg-RX-API-DMAC7.html)
CN (1) CN118510905A (cg-RX-API-DMAC7.html)
WO (1) WO2023106256A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL325122A (en) 2018-02-22 2026-02-01 Akouos Inc Compositions and methods for treating non-age-related hearing impairment in humans

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE23193606T1 (de) * 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
DE102005040211B4 (de) 2005-08-16 2010-02-11 Maquet Cardiopulmonary Ag Verwendung von nichtionischen Estern in einer Beschichtung für mit Blut in Kontakt kommende Oberflächen und medizinische Vorrichtung
US9725485B2 (en) * 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
JP6836999B2 (ja) * 2015-03-24 2021-03-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California アデノ随伴ウイルス変異体及びその使用方法
WO2017197355A2 (en) * 2016-05-13 2017-11-16 4D Molecular Therapeutics Inc. Adeno-associated virus variant capsids and methods of use thereof
US12534739B2 (en) * 2018-10-11 2026-01-27 Decibel Therapeutics, Inc. AAV1 vectors and uses thereof for treatment of otic indications
JP7371954B2 (ja) * 2019-07-12 2023-10-31 株式会社遺伝子治療研究所 ヒト肝臓への遺伝子導入のためのアデノ随伴ウイルスビリオン
CA3153972A1 (en) * 2019-09-09 2021-03-18 Massachusetts Eye And Ear Infirmary Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav
JP7713130B2 (ja) * 2019-09-30 2025-07-25 イーライ リリー アンド カンパニー 遺伝性難聴の処置のためのアデノ随伴ウイルス(aav)システム

Similar Documents

Publication Publication Date Title
US11766487B2 (en) Treatments for retinal disease
JP7666922B2 (ja) 昆虫細胞における向上したaavカプシド産生
EP3717636B1 (en) Adeno-associated virus variant capsids and use for inhibiting angiogenesis
JP7140830B2 (ja) Aav粒子の産生を目的としたベクター
WO2023284879A1 (en) Modified aav capsid for gene therapy and methods thereof
JP2020524498A (ja) 細胞トランスフェクション及び/又はrAAVベクター産生の改善のための増強剤
JP2019521696A5 (cg-RX-API-DMAC7.html)
JP2023535620A5 (cg-RX-API-DMAC7.html)
JP2020527335A5 (cg-RX-API-DMAC7.html)
JP2023513892A (ja) Dna増幅方法
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2023541443A5 (cg-RX-API-DMAC7.html)
CN111876432A (zh) 一组肝靶向新型腺相关病毒的获得及其应用
US20180163229A1 (en) Novel recombinant adeno-associated virus capsids containing a designed ankyrin repeat protein (darpin) or fragment thereof
JP7854125B2 (ja) 新規なデュアルヘルパープラスミド
JP2024537133A (ja) 組換えaav生成のための組成物及び方法
CN117940446A (zh) 衣壳变体及其使用方法
WO2025057943A1 (ja) 内耳に感染性を有するaav変異体
WO2025053118A1 (ja) 短縮型cmvプロモーター配列、及び/又は短縮型ポリアデニル化配列を含む組換えアデノ随伴ウイルス
WO2025241864A1 (zh) 提高腺相关病毒生产效率的方法
HK40096036B (en) Method of making recombinant aavs
HK40096036A (en) Method of making recombinant aavs
RU2020114229A (ru) ВАРИАНТ СРЕДСТВА ДЛЯ RNAi